nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-617954FB·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Molecular Biology·Basis: Full text·Type: Narrative review

The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

Nadja Kupper et al.Nadja Kupper, Berthold Huppertz·2021·Molecular Aspects of Medicine·10.1016/j.mam.2021.100955 ↗

Primary claim

in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

Tentative · cell and animal evidence does not establish the human maternal vascular effect at the certainty stated
In brief

An organised synthesis connects placental vesicle biology with maternal responses, but its vascular-damage claim exceeds the model-based evidence.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Abstract

During pregnancy, there is an intense crosstalk between mother and placenta. During the entire time of pregnancy, the maternal system deals with a huge amount of foreign (fetal) material released from the placenta, which can be referred to as placental exposome. Besides the release of hormones and growth factors, the placenta releases a variety of extracellular vesicles into maternal blood. These vesicles contain specific molecules including proteins, lipids, DNA as well as miRNA, all of which may have specific sites and modes of action on maternal cells. During normal pregnancy, the fine-tuning of factors and vesicles helps maintaining a viable and healthy pregnancy. However, in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system. This review focuses on the different types of placenta-derived extracellular vesicles in pregnancy with special emphasis on the interplay between these placental vesicles and the maternal system. Additionally, it displays new techniques and ideas for the analysis of the placental exposome with placental extracellular vesicles as a key aspect.

Key Claims

Primary finding · Tentative

in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

cell and animal evidence does not establish the human maternal vascular effect at the certainty stated

Abstract
Quote verified
Secondary · Supported

Importantly, the syncytiotrophoblast represents the primary source of placenta-derived extracellular vesicles

cited marker-based studies support placental source attribution with limits on identifying vesicle origins

Section 3.2
Quote verified
Secondary · Tentative

During normal pregnancy, placenta-derived extracellular vesicles are continuously released into the maternal circulation and thus prime the maternal immune system to the ongoing pregnancy

predominantly in vitro immune-cell evidence limits inference about immune priming across pregnancy

Section 4.2
Quote verified
Secondary · Supported

data from different studies as well as their reproducibility may not be comparable since extracellular vesicle diversity is high and isolation protocols differ leading to isolation of a variety of different extracellular vesicle subtypes.

documented mixed preparations support the qualified warning without a quantitative comparison of isolation protocols

Section 7
Quote verified
Secondary · Supported

In contrast to exosomes and microvesicles, the released multinucleated syncytial knots are trapped in the maternal lungs, the first capillary bed of the maternal blood stream behind the placenta

cited anatomical and histological studies support pulmonary trapping of the larger syncytial knots

Section 2.2; Figure 2
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#reporting

General and placental evidence remain distinguishable

Parallel subsections distinguish general vesicle mechanisms from placenta-specific findings, helping readers identify where evidence comes from other cell systems.

↳ Sections 2, 3, 4 and 6

#methodological rigour

Contrary findings complicate the mechanistic account

The review includes non-selective trophoblast miRNA sorting and the absence of endothelial gene-expression differences between healthy and preeclamptic vesicle exposures.

↳ Sections 3.2 and 5

#positioning

Isolation heterogeneity informs the research agenda

Marker overlap and mixed vesicle preparations are connected to difficulties comparing studies and resolving cargo-versus-quantity effects.

↳ Sections 3.1, 6 and 7

Limitations

#contribution

Exposome framing adds limited conceptual advance

The synthesis largely covers mechanisms and open questions already addressed by the contemporary reviews it cites, without developing a distinct explanatory framework.

↳ Sections 1.1–7

#methodological rigour

Literature selection remains undocumented throughout review

No account explains how sources were identified or selected, leaving the coverage and assembly of the evidence base difficult to assess.

↳ Sections 1–7

#reporting

Abstract overstates established maternal vascular effects

The Abstract presents altered placental vesicles as causing vascular harm, while the body relies substantially on cell and animal models and includes a null endothelial-expression comparison.

↳ Abstract; Sections 4.2, 5 and 7

Does this match your read? Add your assessment ↓

Nabu Commentary

The review's parallel treatment of general vesicle biology and placenta-specific findings provides an accessible account of cargo, uptake and maternal responses. Its engagement with marker ambiguity, non-selective RNA sorting and the null endothelial-expression comparison prevents a uniformly affirmative mechanistic narrative. Nevertheless, source selection is undocumented and the exposome framing adds limited advance beyond the cited reviews. The Abstract states maternal vascular harm more definitively than the cell and animal evidence warrants, while the conclusion more appropriately preserves unresolved cargo-versus-quantity questions.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.2±0.1

Contribution
2.9

The review brings placental vesicle biogenesis, cargo, trafficking and maternal responses into one organised account. Its exposome framing and concluding questions largely reiterate the agenda of closely related reviews rather than resolving an uncertainty.

Sections 1.1–7
Methodological Rigour
3.1

The synthesis separates general cell biology from placental evidence and includes findings that complicate its mechanistic account. Source identification and selection are not described, and individual model studies receive limited critical appraisal.

Sections 2–6, particularly Sections 4.2 and 5
Reporting
3.4

Parallel general and placenta-specific subsections make the argument followable. The Abstract's declarative vascular-damage claim is stronger than the model-based evidence and uncertainties presented in the body.

Abstract; Sections 2–5 and 7
Positioning
3.6

The review engages methodological guidance, marker ambiguity, non-selective cargo sorting and a null endothelial-expression result. It connects isolation heterogeneity to unresolved questions, but only partly traces experimental model limitations into claims about maternal physiology.

Sections 2.1, 3.1–3.2, 4.2, 5–7

Lower confidence on Reporting, Positioning — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyNoted

Section 6.2 contains internal references to sections that do not exist. Competing interests are declared as none.

Conflict of interest: declared

Reference IntegrityNoted

158 references in manuscript 155 of 157 checkable references found in an index 1 are books, websites or datasets — counted, but not index-checkable 10 mistyped DOIs matched to the cited work by its details

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Reproductive health and childbirth · Maternal disorders
Type of advanceSynthesis
Route to useNot stated
AdvanceConsolidates
BeneficiariesLarge
CitationsFWCI 0.8
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The strongest synthesized evidence for the primary claim comes from controlled in vitro endothelial studies and animal models showing preeclamptic EVs cause vascular dysfunction under experimental conditions.

The review's conclusions focus on open questions and the need for further research rather than naming any direct real-world application of its synthesized findings.

Pathway

Researchers studying pregnancy biology could identify placental EV-based biomarkers that obstetricians use for early detection of preeclampsia in pregnant women.

Barrier

Conflicting in vitro evidence on whether EV cargo alterations directly cause maternal vascular damage, combined with lack of standardized isolation protocols, limits clinical translation.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Hollow-fibre biomanufacturing and cell-free engineering of HEK293 extracellular vesicles

    2026 · Biological sciences

    Primary claim

    up to 4.83 × 10¹¹/ml of HEK293 EVs were successfully cell-free engineered

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  3. Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy

    Bandres-Meriz, Kunz, Havelund, et al. · 2023 · Clinical medicine

    Primary claim

    palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

    Supported
    Evidence Score
    2.6±0.2
    Reliability
    Concerns

How the rubric works →